Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Hum Mutat. 2019 Dec 19;41(3):641–654. doi: 10.1002/humu.23960

Table 1 –

BCM Visceral Myopathy Cohort overview

All N/Total (%) All ACTG2 N/Total (%) ACTG2 Negative N/Total (%)
Demographics
 Number of Probands 53 33 20
Sex
 Male 16/40 (40) 13/28 (46.4) 3/12 (25)
 Female 24/40 (60) 15/28 (53.6) 9/12 (75)
Clinical Features
 GU Features
  Megacystis 28/36 (77.8) 24/27 (89) 4/9 (44.4)
  Fetal Bladder Procedure 4/35 (11.4) 3/27 (11.1) 1/8 (12.5)
  Catheterization or Vesicostomy 27/34 (79.4) 24/26 (92.3) 3/8 (37.5)
 GI Features
  Microcolon 18/34 (52.9) 16/26 (61.5) 2/8 (25)
  Bilious Emesis 15/32 (46.8) 13/24 (54.2) 2/8 (25)
  TPN Dependence
   Total 11/36 (30.5) 9/27 (33.3) 2/9 (22)
   Partial 17/36 (47.2) 16/27 (59.2) 1/9 (11)
   Minimal 8/36 (22.2) 2/27 (7.4) 6/9 (67)
  Abdominal Surgery 19/36 (52.7) 15/26 (57.7) 4/10 (40)
 GI + GU involvement 33/38 (86.8) 28/28 (100) 5/10 (50)

Note: N indicates number of cases; Total represents cases with complete clinical information.

Abbreviations: BCM, Baylor College of Medicine; Cath, bladder catheterization; GI, gastrointestinal; GU, genitourinary, TPN, total parenteral nutrition.